نتایج جستجو برای: sustained virologic response

تعداد نتایج: 1043902  

Journal: :Gastroenterology 2015
Michael Charlton Edward Gane Michael P Manns Robert S Brown Michael P Curry Paul Y Kwo Robert J Fontana Richard Gilroy Lewis Teperman Andrew J Muir John G McHutchison William T Symonds Diana Brainard Brian Kirby Hadas Dvory-Sobol Jill Denning Sarah Arterburn Didier Samuel Xavier Forns Norah A Terrault

BACKGROUND & AIMS Interferon alfa-based regimens used to treat recurrent hepatitis C virus (HCV) infection after liver transplantation are poorly tolerated, associated with generally modest efficacy, and can interact with immunosuppressive agents. We evaluated the efficacy and safety of an interferon-free regimen of the nucleotide polymerase inhibitor sofosbuvir combined with ribavirin for 24 w...

2012
Catherine Fagard Agathe Rami Patrick Yeni Christine Katlama Jean-Michel Molina Diane Descamps Yazdan Yazdanpanah

Among 103 patients with multidrug-resistant HIV who initiated raltegravir, etravirine, and darunavir/ritonavir-containing regimen in the ANRS 139 TRIO trial, 100 participated in extended follow-up and continued study treatment until week 96. Among them, 87 (87%) received an optimized background therapy including either nucleoside reverse transcriptase inhibitors or enfuvirtide, they were 78 (78...

Journal: :Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2010
Tetsuo Takehara

Antiviral therapy for chronic hepatitis C has advanced dramatically since the discovery of the hepatitis C virus and the introduction of interferon in early 1990's. An initial treatment regimen, 24 weeks of interferon monotherapy, achieved sustained virologic response, which is formally defined at 24 weeks after completion of the treatment, only for 5% of patients with genotype 1 high-viral loa...

Journal: :Annals of internal medicine 2005
S Zeuzem

Undetectable hepatitis C virus (HCV)-specific RNA in serum six months after the end of treatment is the primary aim of antiviral therapy in patients with chronic hepatitis C. Long-term studies confirmed that viral eradication is durable in more than 95% of cases. The high chronification rate of acute hepatitis C (50 to 80%) justifies therapeutic strategies to prevent a chronic course of the inf...

Journal: :Clinical Gastroenterology and Hepatology 2021

Hepatitis C virus infection is causing chronic liver disease, cirrhosis, and hepatocellular carcinoma. By combining direct-acting antivirals (DAAs), high sustained virologic response rates (SVRs) can be achieved. Resistance-associated substitutions (RASs) are commonly observed after DAA failure, especially nonstructural protein 5A (NS5A) RASs may impact retreatment options.1–3 Data on of failur...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید